AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Nautilus Biotechnology, Inc. Director's Dealing 2021

Jun 9, 2021

34183_dirs_2021-06-09_cc32a6f6-ce07-4710-9a18-2a0257aeae91.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nautilus Biotechnology, Inc. (NAUT)
CIK: 0001808805
Period of Report: 2021-06-09

Reporting Person: Murphy Matthew B. (General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	29140	Indirect

Footnotes

F1: Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust.